Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Oct;22(10):1442-1444.
doi: 10.1111/ddg.15487. Epub 2024 Jun 25.

Scaly macules and papules on the extremities and a therapeutic clue

Maximilian Lammer  1 , Matthias Schmuth  1
Affiliations
Case Reports

Scaly macules and papules on the extremities and a therapeutic clue

Maximilian Lammer et al. J Dtsch Dermatol Ges. 2024 Oct.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Inci R, Zagoras T, Kantere D, et al. Porokeratosis is one of the most common genodermatoses and is associated with an increased risk of keratinocyte cancer and melanoma. J Eur Acad Dermatol Venereol. 2023;37(2):420‐427.
    1. Wang J, Liu Y, Liu F, et al. Loss‐of‐function Mutation in PMVK Causes Autosomal Dominant Disseminated Superficial Porokeratosis. Sci Rep. 2016;6:24226.
    1. Zhang S‐Q, Jiang T, Li M, et al. Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis. Nat Genet. 2012;44(10):1156‐1160.
    1. Atzmony L, Lim YH, Hamilton C, et al. Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis‐directed therapy. J Am Acad Dermatol. 2020;82(1):123‐131.
    1. Santa Lucia G, Snyder A, Lateef A, et al. Safety and Efficacy of Topical Lovastatin Plus Cholesterol Cream vs Topical Lovastatin Cream Alone for the Treatment of Disseminated Superficial Actinic Porokeratosis: A Randomized Clinical Trial. JAMA Dermatol. 2023;159(5):488‐495.

Publication types

LinkOut - more resources